Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)
NCT07003919
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
480
Enrollment
INDUSTRY
Sponsor class
Conditions
Allergy
Peanut Allergy
Interventions
COMBINATION_PRODUCT:
DBV712 250 mcg
COMBINATION_PRODUCT:
Placebo
Sponsor
DBV Technologies